Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Healthcare leaders traditionally separate emotion from decision‑making, but a recent hospital closure in New York demonstrates that compassionate leadership can coexist with operational rigor. The tertiary medical center reduced from 700 to 200 beds, faced financial loss, and ultimately closed after 18 months of legal and community resistance. Executives prioritized transparent communication, live Q&A, purposeful rounding, and an open‑door presence, preserving patient safety and staff trust throughout the transition. The experience shows empathy and psychological safety are strategic assets during disruptive change.
Federal policies driven by Health Secretary Robert F. Kennedy Jr. are creating a hostile environment for vaccine developers, prompting companies like Moderna to scale back late‑stage studies. A Texas startup canceled a new manufacturing plant, and a San Diego firm...
Medicare Advantage insurers are confronting a perfect storm of rising medical costs and a flat payment increase of less than 1% announced by CMS for 2026. The new risk‑adjustment formula and stagnant reimbursement fall below the medical‑cost trend, compressing margins...
Dr. Mehmet Oz, CMS administrator, advocated AI avatars as the most effective solution to bridge mental‑health gaps in rural America. He highlighted the chronic shortage of clinicians and argued that agentic AI can conduct early intakes, detect subtle speech cues,...
Researchers engineered mice lacking growth hormone receptors specifically in adipose tissue (Ad‑GHRKO) and observed striking brain benefits in aged males. Compared with control mice, the Ad‑GHRKO group showed increased neuronal activity, reduced neuroinflammation, lower tau phosphorylation, and fewer senescence markers....
Carroll County, Maryland launched a Whole Blood Program in May, enabling paramedics to carry and transfuse 500‑ml Type O‑positive units on scene. The initiative has saved 14 lives and been used 17 times, with 100% survival for internal hemorrhage cases...
"Immune Reset" Rebooting the immune system by depletion of B cells, like a reboot of a computer, to achieve cures vs autoimmune diseases https://t.co/253NtyFmCN
Researchers at Vrije Universiteit Amsterdam built an 80‑compound, three‑dimensional fragment library and screened it against the histamine H1 receptor. Only one fragment (1a) showed activity, but iterative optimization yielded the low‑nanomolar antagonist VUF26691 with picomolar cellular potency. The campaign required...
Prime Healthcare conducted a nine‑month, 13‑hospital trial of two virtual sitter models—an integrated turnkey vendor and a split‑component approach—to enhance patient safety in Phase 2 of its virtual care strategy. The integrated model, which supplies hardware, software, and remote observers, outperformed...
p-tau217 is a breakthrough blood test for risk of developing Alzheimer's disease. Important to know there are sex differences for this biomarker, with women having higher values at baseline and more tau deposition. @JAMANeuro https://t.co/Xrr8SjsiVY https://t.co/eyDt6mgSqR
A psychedelic quickly reduced depression (in patients with major depression disorder) in a small, double-blind placebo randomized trial @NatureMedicine https://t.co/vvug72VGBi https://t.co/Tn58rP0ufS
The fourth quarter of 2025 marked the first quarter‑over‑quarter rise in biopharma job postings, with a 10% increase and a 4% uptick in average listings, despite a 14% year‑over‑year decline. Science/research and development roles grew 14% while clinical positions surged...
The article traces the shifting terminology of digital health records, noting that the "electronic health record" (EHR) label gained popularity during the Bush 43 era while earlier versions were called CPR and later EMR. It argues the rebranding served vendor pricing...
A new Science #Robotics study describes a #bionic eye that can simulate irregular pupils such as a cat’s vertical pupil for precise focus while hunting and a toad's heart-shaped pupil for improved depth perception. https://t.co/p1uZy6rbky https://t.co/X4pzdrnoIi
Direct‑to‑consumer advertising for prescription drugs is resurging, highlighted by Novo Nordisk’s $180 million spend on Ozempic TV spots in 2022 and $189 million in 2023. The ads use upbeat jingles and lifestyle imagery to present the GLP‑1 medication as a gateway to...
The lipid serine hydrolase PNPLA3, especially its I148M mutant, has emerged as a genetically validated driver of MASLD/MASH, prompting a wave of genotype‑focused drug programs. RNA‑based modalities—Arrowhead’s GalNAc‑siRNA ARO‑PNPLA3 and AstraZeneca/Ionis’ GalNAc‑ASO AZD2693—are in clinical trials aiming to lower mutant...
A pragmatic randomized trial in the southeastern US tested a 12‑month produce‑prescription program that gave diabetes patients at risk of food insecurity an $80 monthly debit card for fruits and vegetables. After enrolling 2,155 participants, the intervention showed no significant...
Medicare announced a sweeping transition to value‑based care, extending bundled‑payment and quality‑adjusted reimbursement models to virtually all Medicare‑eligible services. The initiative introduces new performance metrics that link payments directly to patient outcomes, with quarterly reporting requirements for participating providers. Early...
When the LLM rewrites the radiology report, patient understanding is increased and clinical accuracy is maintained. @LancetDigitalH @curtlanglotz @smrabd https://t.co/q2UHebBQG7 https://t.co/IwZAx59brY
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial https://t.co/UF4Lt3g5QK https://t.co/LWuJYD2qGh
At HIMSS26, Greg O'Neill, director of Patient & Family Health Education at ChristianaCare, presented a session titled “A Prescription to End Confusion.” The talk highlighted a new organizational goal to boost health literacy across clinical workflows. O'Neill explained how clearer...
On Jan 2026 the FDA issued updated guidance that relaxes oversight for low‑risk digital health products, including many AI‑enabled clinical decision support tools and consumer wellness wearables. The guidance clarifies which software falls outside the medical device definition, allowing these tools...
Virtual reality (VR) therapy shows rapid clinical effects but remains confined to pilot studies due to a lack of standardized dosage protocols. Researchers highlight wide variation in session length, frequency, and content across studies, preventing reliable comparison and scaling. The...
The article examines a proposed federal framework that would shift health‑affordability dollars into individual‑controlled accounts, highlighting that ownership of the payment infrastructure will decide market winners. It points to the rapid growth of high‑deductible plans, Health Savings Accounts exceeding $100 billion,...
The article contends that an over‑emphasis on formal assessment in residency programs suppresses residents' natural curiosity and deep reasoning. When attendings prioritize grading over dialogue, trainees like June learn to memorize correct answers rather than explore underlying mechanisms. This performance‑driven...
Researchers at Politecnico di Milano have demonstrated a console‑free mixed‑reality teleoperation system for the da Vinci Research Kit, leveraging Microsoft HoloLens 2 to control the robot via hand gestures, head tracking, and speech. The prototype was tested on camera navigation and...
Researchers at the University of Tokyo applied a machine‑learning tool, AI‑IR, to estimate insulin resistance in half a million UK Biobank participants. The analysis revealed insulin resistance as a significant risk factor for twelve distinct cancer types, providing the first...
Roche announced that its anti‑CD20 antibody Gazyva (obinutuzumab) met the primary endpoint in the phase 3 MAJESTY trial for primary membranous nephropathy (pMN). The study showed significantly higher complete remission rates at two years compared with the immunosuppressant tacrolimus, while maintaining...
Cardiovascular disease remains the top U.S. killer, driven by the intertwined cardiovascular‑kidney‑metabolic (CKM) syndrome that links obesity, diabetes, and chronic kidney disease. About one‑third of adults carry three or more CKM risk factors, and 90% meet early‑stage criteria. Monogram Health’s...
Richard Pazdur, longtime FDA oncology leader, resigned after being pressured to endorse a controversial policy that would reduce required drug approval trials from two to one. He said Commissioner Marty Makary breached the traditional independence between the commissioner’s office and...
The MHRA has opened a public consultation proposing that CE‑marked medical devices be recognised indefinitely in Great Britain. Around 90% of devices used in the GB market currently carry a CE mark, and the agency aims to align transition timelines...
The article highlights a persistent gender gap in medical care for menstrual health, noting that up to 75% of menstruating individuals experience PMS and 3‑8% suffer from PMDD, yet these conditions remain underdiagnosed and underfunded. A survey of 3,000 Japanese...
Age‑related decline in O‑GlcNAc Transferase (OGT) activity contributes to neurodegenerative disorders such as Alzheimer’s, Parkinson’s and ALS. Traditional approaches aim to raise O‑GlcNAc levels by inhibiting O‑GlcNAcase, but recent research highlights transcriptional control of OGT as a more direct therapeutic...
In this episode, a16z partner Jorge Conde interviews Novartis CEO Vasant Narasimhan about reshaping the 250‑year‑old conglomerate into a focused medicines company, a move he estimates will unlock $180 billion of value. Narasimhan outlines Novartis’s three platform pillars—cell and gene therapies,...
Researchers have identified inflammatory glycogen produced by gut microbes as a driver of age‑related neurodegeneration, especially in ALS and frontotemporal dementia linked to C9ORF72 mutations. In germ‑free mice lacking C9ORF72, colonization with glycogen‑producing Parabacteroides merdae triggered monocytosis, blood‑brain barrier breakdown,...
The episode examines Epic Systems' recent courtroom setback in the CureIS litigation, focusing on the court's denial of a motion to stay discovery and the nuanced protective order regarding "Highly Confidential – Attorneys' Eyes Only" information. It highlights how Epic's...
César de la Fuente’s Penn team is using artificial intelligence to scour genomes for antimicrobial peptides, creating a library of over one million candidate sequences. The AI has uncovered promising molecules hidden in archaea, venomous species, and even extinct organisms...
A recent national study of 2,300 women aged 21‑65 found that 60.8% still prefer clinician‑collected cervical cancer screening over FDA‑approved at‑home self‑collection kits. While 20.4% expressed interest in home testing, the majority’s preference signals that traditional Pap and HPV specimens...
Novartis released final Phase III ALIGN data showing its oral endothelin‑A antagonist Vanrafia (atrasentan) slowed kidney function decline in adults with IgA nephropathy. The double‑blind, placebo‑controlled trial enrolled 340 biopsy‑confirmed patients who continued optimized RAS inhibition, delivering a 2.39 ml/min/1.73 m² advantage in...
Medtronic has secured FDA clearance for its Stealth AXiS spine‑surgery robotics platform, an integrated solution that combines robotics, planning and navigation in a single workflow. The system features LiveAlign segmental tracking, delivering real‑time visualization of anatomical movement and reducing the need...
Researchers at the AITHYRA Institute introduced a high‑throughput chemical diversification platform that systematically creates molecular‑glue candidates and screens them directly in living cells. Applying the workflow to the leukemia‑associated protein ENL, they identified a small molecule that selectively induces ENL...
Brainomix unveiled its next‑generation Brainomix 360 Stroke platform at the International Stroke Conference, featuring an industry‑first net water uptake (NWU) metric derived from routine non‑contrast CT scans. The platform earned the Red Dot Design Award, highlighting its superior usability and innovative...
In 2013 Dr. Eric Dickson took the helm of UMass Memorial Health as the system teetered on the brink of default and faced declining patient and caregiver satisfaction. He introduced a CEO‑driven lean management system that standardized nine core processes and...
VISIE Inc. announced the launch of its Partner APIs, a robot‑agnostic interface that brings the company’s spatial computing and real‑time scanning capabilities to surgical robotics platforms. Built on gRPC and supporting multiple programming languages, the APIs deliver scanner control, object...
TechRadar’s Graham reviews Sentai, a UK‑made AI voice companion built for seniors living independently. The speaker delivers reminders, medication prompts, and conversational companionship while deliberately avoiding constant listening or surveillance. In testing, Sentri handled emotional cues, emergency alerts, and privacy...
The Royal Marsden NHS Foundation Trust has successfully delivered online adaptive radiotherapy (oART) using an existing Elekta linear accelerator, demonstrating that high‑precision treatment can be achieved without dedicated machines. The system adapts the radiation plan in real time, reducing safety...
Researchers introduced a microneedle patch (MN‑Mg) that simultaneously delivers hydrogen gas and magnesium ions directly into the injured spinal cord. The hydrogen component rapidly scavenges reactive oxygen species, cutting oxidative stress by roughly 55%, while the magnesium release sustains microglial...
The European Commission will launch a call for proposals on 21 April 2026 to fund two large‑scale pilots that deploy cloud‑based AI and generative AI for medical imaging, allocating €9 million under the Digital Europe Programme. The pilots target real‑world clinical settings,...
Researchers have created piezoelectric nerve guidance conduits (NGCs) that incorporate zinc oxide nanoparticles and multidimensional oriented structures. The conduits are fabricated by merging digital light processing (DLP) 3D printing with directional freezing, producing channels and micropores that align regenerating axons....
